Clinical Trial Update: Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing celecoxib and diclofenac for efficacy and safety in Chinese patients with ankylosing spondylitis has completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Celecoxib (Celecoxib)
• Diclofenac (diclofenac)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2011-08-23